1. Home
  2. SILO vs ISPC Comparison

SILO vs ISPC Comparison

Compare SILO & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SILO
  • ISPC
  • Stock Information
  • Founded
  • SILO 2010
  • ISPC 2009
  • Country
  • SILO United States
  • ISPC United States
  • Employees
  • SILO N/A
  • ISPC N/A
  • Industry
  • SILO Apparel
  • ISPC Precision Instruments
  • Sector
  • SILO Consumer Discretionary
  • ISPC Health Care
  • Exchange
  • SILO Nasdaq
  • ISPC Nasdaq
  • Market Cap
  • SILO 8.0M
  • ISPC 6.9M
  • IPO Year
  • SILO N/A
  • ISPC 2021
  • Fundamental
  • Price
  • SILO $0.54
  • ISPC $0.78
  • Analyst Decision
  • SILO
  • ISPC
  • Analyst Count
  • SILO 0
  • ISPC 0
  • Target Price
  • SILO N/A
  • ISPC N/A
  • AVG Volume (30 Days)
  • SILO 869.8K
  • ISPC 504.9K
  • Earning Date
  • SILO 11-12-2025
  • ISPC 11-14-2025
  • Dividend Yield
  • SILO N/A
  • ISPC N/A
  • EPS Growth
  • SILO N/A
  • ISPC N/A
  • EPS
  • SILO N/A
  • ISPC N/A
  • Revenue
  • SILO $72,102.00
  • ISPC $5,908,088.00
  • Revenue This Year
  • SILO $1.86
  • ISPC $35.93
  • Revenue Next Year
  • SILO N/A
  • ISPC N/A
  • P/E Ratio
  • SILO N/A
  • ISPC N/A
  • Revenue Growth
  • SILO N/A
  • ISPC N/A
  • 52 Week Low
  • SILO $0.40
  • ISPC $0.64
  • 52 Week High
  • SILO $3.37
  • ISPC $5.48
  • Technical
  • Relative Strength Index (RSI)
  • SILO 40.10
  • ISPC 40.77
  • Support Level
  • SILO $0.50
  • ISPC $0.75
  • Resistance Level
  • SILO $0.59
  • ISPC $0.86
  • Average True Range (ATR)
  • SILO 0.05
  • ISPC 0.07
  • MACD
  • SILO -0.00
  • ISPC 0.01
  • Stochastic Oscillator
  • SILO 54.31
  • ISPC 31.20

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

About ISPC iSpecimen Inc.

iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.

Share on Social Networks: